Is This the Answer to Expensive Hepatitis-C Cures?

The fierce battle over the hepatitis C space continued to intensify today, as the market received a huge amount of clinical trial data news, from Gilead (NASDAQ: GILD  ) , Bristol-Myers Squibb (NYSE: BMY  ) , and now, Merck (NYSE: MRK  ) . Merck marks the newest entrant to the field with an all-oral regimen for genotype 1, and with its cure rate nearly on par with Gilead's at 98% after 12 weeks, and its treatment also consisting of a single pill per day, this could spell dangerous new competition for Gilead and its drug Sovaldi.

In this video, Motley Fool health care analyst David Williamson takes a look at Gilead, the big dog in this space, and compares Sovaldi with Merck's drug. David highlights all the reasons that this may represent a competitive threat down the road, but says that in the short term, the far greater risk to Sovaldi may be the pushback the drug is receiving due to its extremely high cost.

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion dollar industry." And the technology  behind is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and it's ability to make life-changing medical solutions never thought possible.  To learn how you can invest in this unbelievable new technology, click here now to see our free report.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2914669, ~/Articles/ArticleHandler.aspx, 10/21/2014 2:43:01 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement